Aleksandra Gawlik-Lipinski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aleksandra Gawlik-Lipinski has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Paul Jaravata Rabe
School of Public Health, Imperial College London, London, United Kingdom
1 shared publication - Amy Hai Yan Chan
The University of Auckland
1 shared publication - Anna Vanoverschelde
Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium
1 shared publication - Anthony Paulo Sunjaya
School of Population Health and The George Institute for Global Health, UNSW Sydney, Sydney, Australia
1 shared publication - Apolline Gonsard
Department of Pediatric Pulmonology and Allergology, University Hospital Necker-Enfants Malades, AP-HP, Paris, France
1 shared publication - Ayşe Önal Aral
Pulmonary Diseases Clinic, Ankara Gölbaşı State Hospital, Gölbaşı/Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 16 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e88325
Implementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review
Background: Digital health offers opportunities for safe, equitable, and accessible care, and its integration into respiratory care is a strategic priority for the European Respiratory Society. However, sustainable implementation remains complex, and guidance for health care systems is limited. Objective: This study aimed to undertake a scoping review of the published initiatives that have implemented digital respiratory technologies into real-world routine clinical practice over the past decade, identify the technologies used, implementation strategies used, the challenges and supports they encountered, and the lessons they reported for making care more equitable, strengthening patient-professional relationships, improving the patient journey, and reducing environmental impact. Methods: Following Arksey and O’Malley’s methodology, we searched ten databases (December 2013‐2023 [updated April 2025 and February 2026]): MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Library, Web of Science, Scopus, IEEE Xplore, CABI Global Health, and WHO Medicus; and used key domains in the commonly used implementation frameworks such as the Consolidated Framework for Implementation Research (CFIR), Nonadaptation, Abandonment, and Challenges to the Scale-up, Spread, and Sustainability of Health and Care Technologies (NASSS), and the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to categorize results and understand methodologies used. As a scoping review, we mapped the available evidence, rather than synthesizing outcomes, appraising study quality, or estimating effectiveness. To broaden coverage and strengthen interpretation, we crowdsourced additional studies and sought feedback on our preliminary findings from a network of respiratory experts across 17 countries. Results: Overall, 24,672 studies were identified; after deduplication, 14,811 were screened; 84 studies from 31 countries were included in the final review. The digital respiratory technologies comprised apps, platforms, chatbots, and smart devices. Reported technological functionalities encompassed remote consultation, clinician monitoring, video directly observed therapy, remote rehabilitation training, self-management support, education, monitoring medication adherence, and a school-based remote clinic. CFIR, RE-AIM, and the plan-do-study-act (PDSA) cycle were the most widely used frameworks. Successful implementation used simple technologies that fitted existing workflows and avoided additional workload. Co-development and trust-building with end-users influenced motivation and adoption, while leadership, team cohesion, and communication facilitated success. Barriers included insufficient resources, poor interoperability, lack of funding and reimbursement, and limited technical support. Conclusions: This scoping review provides a cross-condition review of digital respiratory technologies implemented in routine clinical practice. Unlike previous disease-specific or experimental-focused reviews, our innovative approach used established implementation Theories, Models, and Frameworks (TMFs) to identify shared barriers and enablers across diverse populations and health care systems. We summarize key implementation domains in state-of-the-art digital respiratory care and identify major gaps related to health equity, patient–clinician trust, continuity of support, and environmental sustainability. These findings emphasize the value of using implementation TMFs for scaling effective, patient-centered digital respiratory care in real-world settings.
- 16 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e88325
Open AccessImplementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review
Background: Digital health offers opportunities for safe, equitable, and accessible care, and its integration into respiratory care is a strategic priority for the European Respiratory Society. However, sustainable implementation remains complex, and guidance for health care systems is limited. Objective: This study aimed to undertake a scoping review of the published initiatives that have implemented digital respiratory technologies into real-world routine clinical practice over the past decade, identify the technologies used, implementation strategies used, the challenges and supports they encountered, and the lessons they reported for making care more equitable, strengthening patient-professional relationships, improving the patient journey, and reducing environmental impact. Methods: Following Arksey and O’Malley’s methodology, we searched ten databases (December 2013‐2023 [updated April 2025 and February 2026]): MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Library, Web of Science, Scopus, IEEE Xplore, CABI Global Health, and WHO Medicus; and used key domains in the commonly used implementation frameworks such as the Consolidated Framework for Implementation Research (CFIR), Nonadaptation, Abandonment, and Challenges to the Scale-up, Spread, and Sustainability of Health and Care Technologies (NASSS), and the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to categorize results and understand methodologies used. As a scoping review, we mapped the available evidence, rather than synthesizing outcomes, appraising study quality, or estimating effectiveness. To broaden coverage and strengthen interpretation, we crowdsourced additional studies and sought feedback on our preliminary findings from a network of respiratory experts across 17 countries. Results: Overall, 24,672 studies were identified; after deduplication, 14,811 were screened; 84 studies from 31 countries were included in the final review. The digital respiratory technologies comprised apps, platforms, chatbots, and smart devices. Reported technological functionalities encompassed remote consultation, clinician monitoring, video directly observed therapy, remote rehabilitation training, self-management support, education, monitoring medication adherence, and a school-based remote clinic. CFIR, RE-AIM, and the plan-do-study-act (PDSA) cycle were the most widely used frameworks. Successful implementation used simple technologies that fitted existing workflows and avoided additional workload. Co-development and trust-building with end-users influenced motivation and adoption, while leadership, team cohesion, and communication facilitated success. Barriers included insufficient resources, poor interoperability, lack of funding and reimbursement, and limited technical support. Conclusions: This scoping review provides a cross-condition review of digital respiratory technologies implemented in routine clinical practice. Unlike previous disease-specific or experimental-focused reviews, our innovative approach used established implementation Theories, Models, and Frameworks (TMFs) to identify shared barriers and enablers across diverse populations and health care systems. We summarize key implementation domains in state-of-the-art digital respiratory care and identify major gaps related to health equity, patient–clinician trust, continuity of support, and environmental sustainability. These findings emphasize the value of using implementation TMFs for scaling effective, patient-centered digital respiratory care in real-world settings.
- Open Access
- 19 August 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (8) , e71255
Risk Factors for Life‐Threatening Asthma Attacks and Asthma‐Related Mortality in Children—A Systematic Review
Background: Awareness of factors associated with life‐threatening asthma attacks and asthma mortality is essential for risk prediction in asthma care. There is limited evidence to inform risk factors in children and young people (CYP). The aim of this systematic review is to synthesize existing data to report risk factors for life‐threatening asthma attacks and asthma deaths in CYP. Methods: This review followed PRISMA‐reporting‐guidelines and was registered on PROSPERO (CRD42023494203). We included observational studies of CYP aged 0−18 years with asthma, published in English, from 2000 to the present, exploring variables influencing asthma mortality and life‐threatening attacks (defined as intensive care [ICU] admissions). CINAHL, MEDLINE, Central Cochrane Library, and Scopus databases were searched. Reference lists of eligible studies were screened. The MEDLINE search strategy was adapted across the databases. Results were synthesized narratively. Results: Six studies met our inclusion criteria (five retrospective cohort, one case‐control study). All were conducted in high‐income countries. In descending order of strength of association, factors found to be associated with ICU admissions were: high salbutamol use, previous hospitalization, low socioeconomic status, allergies, Black ethnicity, prescription of asthma medications, history of pneumonia, rural location, adolescence, paternal asthma, and co‐existing comorbidity. For the outcome of mortality, one study reported a sevenfold risk of asthma death in children of Black ethnicity compared with White. The included studies had low quality of evidence by the GRADE assessment. Conclusion: The small number and high heterogeneity between available studies, identifies a need for robust epidemiological studies and better risk prediction for near‐fatal and fatal attacks in CYP‐asthma.
- 19 August 2025
- Published by Wiley in Pediatric Pulmonology
- Vol. 60 (8) , e71255
Open AccessRisk Factors for Life‐Threatening Asthma Attacks and Asthma‐Related Mortality in Children—A Systematic Review
Background: Awareness of factors associated with life‐threatening asthma attacks and asthma mortality is essential for risk prediction in asthma care. There is limited evidence to inform risk factors in children and young people (CYP). The aim of this systematic review is to synthesize existing data to report risk factors for life‐threatening asthma attacks and asthma deaths in CYP. Methods: This review followed PRISMA‐reporting‐guidelines and was registered on PROSPERO (CRD42023494203). We included observational studies of CYP aged 0−18 years with asthma, published in English, from 2000 to the present, exploring variables influencing asthma mortality and life‐threatening attacks (defined as intensive care [ICU] admissions). CINAHL, MEDLINE, Central Cochrane Library, and Scopus databases were searched. Reference lists of eligible studies were screened. The MEDLINE search strategy was adapted across the databases. Results were synthesized narratively. Results: Six studies met our inclusion criteria (five retrospective cohort, one case‐control study). All were conducted in high‐income countries. In descending order of strength of association, factors found to be associated with ICU admissions were: high salbutamol use, previous hospitalization, low socioeconomic status, allergies, Black ethnicity, prescription of asthma medications, history of pneumonia, rural location, adolescence, paternal asthma, and co‐existing comorbidity. For the outcome of mortality, one study reported a sevenfold risk of asthma death in children of Black ethnicity compared with White. The included studies had low quality of evidence by the GRADE assessment. Conclusion: The small number and high heterogeneity between available studies, identifies a need for robust epidemiological studies and better risk prediction for near‐fatal and fatal attacks in CYP‐asthma.